Igartua M - Search Results

1

Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.

Hernando S, Gartziandia O, Herran E, Pedraz JL, Igartua M, Hernandez RM. Hernando S, et al. Among authors: igartua m. Nanomedicine (Lond). 2016 May;11(10):1267-85. doi: 10.2217/nnm-2016-0019. Epub 2016 Apr 14. Nanomedicine (Lond). 2016. PMID: 27077453 Review.

2

Encapsulated cell technology: from research to market.

Orive G, Hernández RM, Gascón AR, Igartua M, Pedraz JL. Orive G, et al. Among authors: igartua m. Trends Biotechnol. 2002 Sep;20(9):382-7. doi: 10.1016/s0167-7799(02)02037-1. Trends Biotechnol. 2002. PMID: 12175769 Review.

3

Controversies over stem cell research.

Orive G, Hernández RM, Gascón AR, Igartua M, Pedraz JL. Orive G, et al. Among authors: igartua m. Trends Biotechnol. 2003 Mar;21(3):109-12. doi: 10.1016/S0167-7799(03)00003-9. Trends Biotechnol. 2003. PMID: 12628366

4

A glimmer of hope for diabetics?

Orive Arroyo G, Hernánedez RM, Gascón AR, Igartua M, Pedraz JL. Orive Arroyo G, et al. Among authors: igartua m. Trends Biotechnol. 2003 Jul;21(7):289-90. doi: 10.1016/S0167-7799(03)00143-4. Trends Biotechnol. 2003. PMID: 12837610

5

Gamma-irradiation effects on biopharmaceutical properties of PLGA microspheres loaded with SPf66 synthetic vaccine.

Igartua M, Hernández RM, Rosas JE, Patarroyo ME, Pedraz JL. Igartua M, et al. Eur J Pharm Biopharm. 2008 Jun;69(2):519-26. doi: 10.1016/j.ejpb.2007.12.014. Epub 2007 Dec 25. Eur J Pharm Biopharm. 2008. PMID: 18280123

6

Topical resiquimod: a promising adjuvant for vaccine development?

Igartua M, Pedraz JL. Igartua M, et al. Expert Rev Vaccines. 2010 Jan;9(1):23-7. doi: 10.1586/erv.09.135. Expert Rev Vaccines. 2010. PMID: 20021302

7

In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: level A in vitro-in vivo correlation.

Ochoa L, Igartua M, Hernández RM, Solinís MA, Gascón AR, Pedraz JL. Ochoa L, et al. Among authors: igartua m. Eur J Pharm Biopharm. 2010 Jun;75(2):232-7. doi: 10.1016/j.ejpb.2010.02.008. Epub 2010 Feb 14. Eur J Pharm Biopharm. 2010. PMID: 20159037

8

Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides.

Mata E, Igartua M, Hernández RM, Rosas JE, Patarroyo ME, Pedraz JL. Mata E, et al. Among authors: igartua m. Drug Deliv. 2010 Sep-Oct;17(7):490-9. doi: 10.3109/10717544.2010.483254. Drug Deliv. 2010. PMID: 20500129

9

Design of a composite drug delivery system to prolong functionality of cell-based scaffolds.

Murua A, Herran E, Orive G, Igartua M, Blanco FJ, Pedraz JL, Hernández RM. Murua A, et al. Among authors: igartua m. Int J Pharm. 2011 Apr 4;407(1-2):142-50. doi: 10.1016/j.ijpharm.2010.11.022. Epub 2010 Nov 19. Int J Pharm. 2011. PMID: 21094235

10

Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate.

Mata E, Igartua M, Patarroyo ME, Pedraz JL, Hernández RM. Mata E, et al. Among authors: igartua m. Eur J Pharm Sci. 2011 Sep 18;44(1-2):32-40. doi: 10.1016/j.ejps.2011.05.015. Epub 2011 Jun 15. Eur J Pharm Sci. 2011. PMID: 21699977

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page